Biotechnology Assets S.A. (BST) — Capital Reinvestment Ratio
Biotechnology Assets S.A. (BST) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (€658.13K) in capital expenditures (€1.99K). See Biotechnology Assets S.A. balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Biotechnology Assets S.A. Capital Reinvestment Ratio (2015–2023)
This chart tracks Biotechnology Assets S.A.'s Capital Reinvestment Ratio across 5 annual periods. Check Biotechnology Assets S.A. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Biotechnology Assets S.A. (2015–2023)
Year-by-year Capital Reinvestment Ratio for Biotechnology Assets S.A. from 2015 to 2023. For live market cap and broader valuation context, see BST market cap.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 6.83x | €47.74K | €325.97K | ▲ +15235.3% |
| 2020 | 0.04x | €8.79 Million | €391.53K | ▼ -99.4% |
| 2017 | 7.33x | €213.49K | €1.56 Million | ▲ +508.5% |
| 2016 | 1.20x | €2.71 Million | €3.27 Million | ▼ -82.2% |
| 2015 | 6.75x | €158.16K | €1.07 Million | — |